Vergelijking

Glepaglutide vs. Selank

Twee peptiden naast elkaar — identiteit, bewijsbasis, juridische status en bekende bijwerkingen.

Identiteit

Categorie

Onderzoek (overig)

CAS-nr.

geen gegevens

129954-34-3

Molecuulmassa

geen gegevens

751.85 g/mol

Halfwaardetijd

geen gegevens

0.3 h

Sequentie

geen gegevens

Thr-Lys-Pro-Arg-Pro-Gly-Pro

Werkingsmechanisme

Glepaglutide

As a GLP-2 receptor agonist, glepaglutide has a trophic effect on the intestinal mucosa, enlarging the absorptive surface and thereby improving intestinal uptake of nutrients and fluid.

Selank

Selank is a glyproline-tuftsin analog. Proposed mechanisms include modulation of the GABAergic system, effects on serotonin bioavailability, and influence on enkephalinases. Animal studies show anxiolytic and neuroprotective markers; a clear receptor target is not established.

Bewijsbasis

Hoogste bewijs

Humane RCT

Humane studie

Studies

waarvan bij mensen

Geregistreerde effecten

Openstaande tegenstrijdigheden

Gedocumenteerde bijwerkingen

Juridische status

Country	Glepaglutide	Selank
Duitsland	Niet goedgekeurd	Niet goedgekeurd
RU	—	Op recept
Verenigde Staten	Niet goedgekeurd	Niet goedgekeurd

Volledige vermeldingen

Glepaglutide

Volledige vermelding →

Selank

Volledige vermelding →

Frequently asked questions

What is the difference between Glepaglutide and Selank?: Glepaglutide is classified as "Onderzoek (overig)", while Selank is classified as "Onderzoek (overig)". Glepaglutide: Glepaglutide is a long-acting GLP-2 analogue (Zealand Pharma) intended to reduce the need for parenteral support in short bowel syndrome. Selank: Synthetic heptapeptide derived from natural tuftsin. Approved as an anxiolytic (Selank) in Russia and some CIS states. Western phase-3 trials are absent; efficacy assessment relies on Russian research literature. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Glepaglutide or Selank?: The highest available evidence level is "Humane RCT" for Glepaglutide and "Humane studie" for Selank. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Glepaglutide and Selank in Germany and the United States?: Duitsland: Glepaglutide — Niet goedgekeurd, Selank — Niet goedgekeurd. Verenigde Staten: Glepaglutide — Niet goedgekeurd, Selank — Niet goedgekeurd. These are factual summaries with source and review date on the individual pages.

Country

Glepaglutide

Selank

Duitsland

Niet goedgekeurd

—

Op recept

Verenigde Staten

Niet goedgekeurd

Frequently asked questions

What is the difference between Glepaglutide and Selank?

Glepaglutide is classified as "Onderzoek (overig)", while Selank is classified as "Onderzoek (overig)". Glepaglutide: Glepaglutide is a long-acting GLP-2 analogue (Zealand Pharma) intended to reduce the need for parenteral support in short bowel syndrome. Selank: Synthetic heptapeptide derived from natural tuftsin. Approved as an anxiolytic (Selank) in Russia and some CIS states. Western phase-3 trials are absent; efficacy assessment relies on Russian research literature. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Glepaglutide or Selank?

The highest available evidence level is "Humane RCT" for Glepaglutide and "Humane studie" for Selank. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Glepaglutide and Selank in Germany and the United States?

Duitsland: Glepaglutide — Niet goedgekeurd, Selank — Niet goedgekeurd. Verenigde Staten: Glepaglutide — Niet goedgekeurd, Selank — Niet goedgekeurd. These are factual summaries with source and review date on the individual pages.